These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10951695)

  • 21. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
    Lowe DB; Shearer MH; Tarbox JA; Kang HS; Jumper CA; Bright RK; Kennedy RC
    Virology; 2005 Feb; 332(1):28-37. PubMed ID: 15661138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic hibernomas in transgenic mice expressing an alpha-amylase-SV40 T antigen hybrid gene.
    Fox N; Crooke R; Hwang LH; Schibler U; Knowles BB; Solter D
    Science; 1989 Apr; 244(4903):460-3. PubMed ID: 2785714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene.
    Nöckel J; van den Engel NK; Winter H; Hatz RA; Zimmermann W; Kammerer R
    BMC Cancer; 2006 Mar; 6():57. PubMed ID: 16536871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
    Schmidt K; Zilio S; Schmollinger JC; Bronte V; Blankenstein T; Willimsky G
    Blood; 2013 Mar; 121(10):1740-8. PubMed ID: 23305737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma.
    Stahl S; Sacher T; Bechtold A; Protzer U; Ganss R; Hämmerling GJ; Arnold B; Garbi N
    Immunol Lett; 2009 Mar; 123(1):31-7. PubMed ID: 19428549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SV40 rodent tumour models as paradigms of human disease: transgenic mouse models.
    Furth PA
    Dev Biol Stand; 1998; 94():281-7. PubMed ID: 9776248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen.
    Ihler F; Vetter EV; Pan J; Kammerer R; Debey-Pascher S; Schultze JL; Zimmermann W; Enders G
    PLoS One; 2012; 7(1):e29846. PubMed ID: 22253802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.
    Shibata MA; Jorcyk CL; Devor DE; Yoshidome K; Rulong S; Resau J; Roche N; Roberts AB; Ward JM; Green JE
    Carcinogenesis; 1998 Jan; 19(1):195-205. PubMed ID: 9472712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA cancer vaccination strategies target SV40 large tumour antigen in a murine experimental metastasis model.
    Watts AM; Bright RK; Kennedy RC
    Dev Biol (Basel); 2000; 104():143-7. PubMed ID: 11713812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune control of SV40-induced tumors in mice.
    Pan S; Abramczuk J; Knowles BB
    Int J Cancer; 1987 Jun; 39(6):722-8. PubMed ID: 3034805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
    Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
    Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice.
    Wettstein PJ; Jewett L; Faas S; Brinster RL; Knowles BB
    Immunogenetics; 1988; 27(6):436-41. PubMed ID: 2836306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of viral T-antigen in pathological tissues from transgenic mice carrying JC-SV40 chimeric DNAs.
    Ressetar HG; Prakash O; Frisque RJ; Webster HD; Re RN; Stoner GL
    Mol Chem Neuropathol; 1993 Sep; 20(1):59-79. PubMed ID: 8251033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients.
    Bright RK; Kimchi ET; Shearer MH; Kennedy RC; Pass HI
    Cancer Immunol Immunother; 2002 Feb; 50(12):682-90. PubMed ID: 11862420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model.
    Romieu R; Baratin M; Kayibanda M; Lacabanne V; Ziol M; Guillet JG; Viguier M
    J Immunol; 1998 Nov; 161(10):5133-7. PubMed ID: 9820481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones.
    Tanaka Y; Tevethia SS
    J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
    Bright RK; Shearer MH; Pass HI; Kennedy RC
    Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.
    Lowe DB; Shearer MH; Aldrich JF; Winn RE; Jumper CA; Kennedy RC
    J Virol; 2010 Oct; 84(19):10121-30. PubMed ID: 20668083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model.
    Bourquin C; von der Borch P; Zoglmeier C; Anz D; Sandholzer N; Suhartha N; Wurzenberger C; Denzel A; Kammerer R; Zimmermann W; Endres S
    J Immunol; 2010 Aug; 185(4):2580-8. PubMed ID: 20644173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.